{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:11:23Z","timestamp":1787843483027,"version":"build-2784847793"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004799","name":"Australian Dental Research Foundation","doi-asserted-by":"publisher","award":["209-2017"],"award-info":[{"award-number":["209-2017"]}],"id":[{"id":"10.13039\/501100004799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004799","name":"Australian Dental Research Foundation","doi-asserted-by":"publisher","award":["209-2017"],"award-info":[{"award-number":["209-2017"]}],"id":[{"id":"10.13039\/501100004799","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Oral and intestinal mucositis are debilitating inflammatory diseases observed in cancer patients undergoing chemo-radiotherapy. These are devastating clinical conditions which often lead to treatment disruption affecting underlying malignancy management. Although alimentary tract mucositis involves the entire gastrointestinal tract, oral and intestinal mucositis are often studied independently utilizing distinct organ-specific pre-clinical models. This approach has however hindered the development of potentially effective whole-patient treatment strategies. We now characterize a murine model of alimentary tract mucositis using 5-Fluorouracil (5-FU). Mice were given 5-FU intravenously (50\u00a0mg\/kg) or saline every 48\u00a0h for 2\u00a0weeks. Post initial injection, mice were monitored clinically for weight loss and diarrhea. The incidence and extent of oral mucositis was assessed macroscopically. Microscopical and histomorphometric analyses of the tongue and intestinal tissues were conducted at 3 interim time points during the experimental period. Repeated 5-FU treatment caused severe oral and intestinal atrophy, including morphological damage, accompanied by body weight loss and mild to moderate diarrhea in up to 77.8% of mice. Oral mucositis was clinically evident throughout the observation period in 88.98% of mice. Toluidine blue staining of the tongue revealed that the ulcer size peaked at day-14. In summary, we have developed a model reproducing the clinical and histologic features of both oral and intestinal mucositis, which may represent a useful in vivo pre-clinical model for the study of chemotherapy-induced alimentary tract mucositis and the development of preventative therapies.<\/jats:p>","DOI":"10.1038\/s41598-023-28486-3","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T10:02:37Z","timestamp":1674640957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Characterization of a novel dual murine model of chemotherapy-induced oral and intestinal mucositis"],"prefix":"10.1038","volume":"13","author":[{"given":"Ali I.","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Celentano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Paolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun T.","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine A.","family":"O\u2019 Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"key":"28486_CR1","doi-asserted-by":"crossref","unstructured":"Scully, C., Sonis, S. & Diz, P. D. Oral mucositis. Oral Diseases, 229 (2006).","DOI":"10.1111\/j.1601-0825.2006.01258.x"},{"key":"28486_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1634\/theoncologist.3-6-446","volume":"3","author":"JL Pico","year":"1998","unstructured":"Pico, J. L., Avila-Garavito, A. & Naccache, P. Mucositis: Its occurrence, consequences, and treatment in the oncology setting. Oncologist 3, 446\u2013451 (1998).","journal-title":"Oncologist"},{"key":"28486_CR3","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1136\/gut.47.5.632","volume":"47","author":"D Keefe","year":"2000","unstructured":"Keefe, D., Brealey, J., Goland, G. & Cummins, A. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 47, 632\u2013637 (2000).","journal-title":"Gut"},{"key":"28486_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00520-003-0550-9","volume":"12","author":"DM Keefe","year":"2004","unstructured":"Keefe, D. M. Gastrointestinal mucositis: A new biological model. Support. Care Cancer 12, 6\u20139 (2004).","journal-title":"Support. Care Cancer"},{"key":"28486_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/00130404-200609000-00004","volume":"12","author":"RV Lalla","year":"2006","unstructured":"Lalla, R. V. & Peterson, D. E. Treatment of mucositis, including new medications. Cancer J. 12, 348\u2013354 (2006).","journal-title":"Cancer J."},{"key":"28486_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3892\/mco.2014.253","volume":"2","author":"MI Campos","year":"2014","unstructured":"Campos, M. I., Campos, C. N., Aarestrup, F. M. & Aarestrup, B. J. Oral mucositis in cancer treatment: Natural history, prevention and treatment. Mol. Clin. Oncol. 2, 337\u2013340. https:\/\/doi.org\/10.3892\/mco.2014.253 (2014).","journal-title":"Mol. Clin. Oncol."},{"key":"28486_CR7","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1002\/cncr.20162","volume":"100","author":"ST Sonis","year":"2004","unstructured":"Sonis, S. T. et al. Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100, 1995\u20132025. https:\/\/doi.org\/10.1002\/cncr.20162 (2004).","journal-title":"Cancer"},{"key":"28486_CR8","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00520-013-1810-y","volume":"21","author":"N Al-Dasooqi","year":"2013","unstructured":"Al-Dasooqi, N. et al. Emerging evidence on the pathobiology of mucositis. Support Care Cancer 21, 2075\u20132083. https:\/\/doi.org\/10.1007\/s00520-013-1810-y (2013).","journal-title":"Support Care Cancer"},{"key":"28486_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/CCO.0000000000000180","volume":"27","author":"A Villa","year":"2015","unstructured":"Villa, A. & Sonis, S. T. Mucositis: Pathobiology and management. Curr. Opin. Oncol. 27, 159\u2013164. https:\/\/doi.org\/10.1097\/CCO.0000000000000180 (2015).","journal-title":"Curr. Opin. Oncol."},{"key":"28486_CR10","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/cncr.28592","volume":"120","author":"RV Lalla","year":"2014","unstructured":"Lalla, R. V. et al. MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 120, 1453\u20131461 (2014).","journal-title":"Cancer"},{"key":"28486_CR11","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/CAD.0b013e3283462086","volume":"22","author":"ST Sonis","year":"2011","unstructured":"Sonis, S. T. Oral mucositis. Anticancer Drugs 22, 607\u2013612. https:\/\/doi.org\/10.1097\/CAD.0b013e3283462086 (2011).","journal-title":"Anticancer Drugs"},{"key":"28486_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.critrevonc.2014.12.009","volume":"94","author":"NSS Kuiken","year":"2015","unstructured":"Kuiken, N. S. S., Rings, E. H. H. M. & Tissing, W. J. E. Risk analysis, diagnosis and management of gastrointestinal mucositis in pediatric cancer patients. Crit. Rev. Oncol. Hematol. 94, 87\u201397. https:\/\/doi.org\/10.1016\/j.critrevonc.2014.12.009 (2015).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"28486_CR13","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1093\/annonc\/mdp596","volume":"21","author":"AH Herbers","year":"2010","unstructured":"Herbers, A. H., Feuth, T., Donnelly, J. P. & Blijlevens, N. M. Citrulline-based assessment score: First choice for measuring and monitoring intestinal failure after high-dose chemotherapy. Annals Oncol. Off. J. the Eur. Soc. Med. Oncol. 21, 1706\u20131711. https:\/\/doi.org\/10.1093\/annonc\/mdp596 (2010).","journal-title":"Annals Oncol. Off. J. the Eur. Soc. Med. Oncol."},{"key":"28486_CR14","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1007\/s00520-017-3752-2","volume":"25","author":"NSS Kuiken","year":"2017","unstructured":"Kuiken, N. S. S., Rings, E. H. H. M., Blijlevens, N. M. A. & Tissing, W. J. E. Biomarkers and non-invasive tests for gastrointestinal mucositis. Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer 25, 2933\u20132941. https:\/\/doi.org\/10.1007\/s00520-017-3752-2 (2017).","journal-title":"Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"key":"28486_CR15","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/cncr.11671","volume":"98","author":"LS Elting","year":"2003","unstructured":"Elting, L. S. et al. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98, 1531\u20131539. https:\/\/doi.org\/10.1002\/cncr.11671 (2003).","journal-title":"Cancer"},{"key":"28486_CR16","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1002\/cncr.23898","volume":"113","author":"LS Elting","year":"2008","unstructured":"Elting, L. S. et al. Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: Demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer 113, 2704\u20132713. https:\/\/doi.org\/10.1002\/cncr.23898 (2008).","journal-title":"Cancer"},{"key":"28486_CR17","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/hed.10318","volume":"25","author":"C Scully","year":"2003","unstructured":"Scully, C., Epstein, J. & Sonis, S. Oral mucositis: A challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis. Head Neck 25, 1057\u20131070 (2003).","journal-title":"Head Neck"},{"key":"28486_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0167-8140(01)00358-9","volume":"60","author":"SM Bentzen","year":"2001","unstructured":"Bentzen, S. M., Saunders, M. I., Dische, S. & Bond, S. J. Radiotherapy-related early morbidity in head and neck cancer: Quantitative clinical radiobiology as deduced from the CHART trial. Radiother. Oncol. 60, 123\u2013135 (2001).","journal-title":"Radiother. Oncol."},{"key":"28486_CR19","first-page":"215","volume":"16","author":"M Georgiou","year":"2012","unstructured":"Georgiou, M., Patapatiou, G., Domoxoudis, S., Pistevou-Gompaki, K. & Papanikolaou, A. Oral Mucositis: Understanding the pathology and management. Hippokratia 16, 215\u2013216 (2012).","journal-title":"Hippokratia"},{"key":"28486_CR20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/s0167-8140(02)00404-8","volume":"66","author":"A Trotti","year":"2003","unstructured":"Trotti, A. et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiother. Oncol. 66, 253\u2013262. https:\/\/doi.org\/10.1016\/s0167-8140(02)00404-8 (2003).","journal-title":"Radiother. Oncol."},{"key":"28486_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/cncr.21622","volume":"106","author":"M Vera-Llonch","year":"2006","unstructured":"Vera-Llonch, M., Oster, G., Hagiwara, M. & Sonis, S. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 106, 329\u2013336 (2006).","journal-title":"Cancer"},{"key":"28486_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3322\/caac.21704","volume":"72","author":"S Elad","year":"2022","unstructured":"Elad, S., Yarom, N., Zadik, Y., Kuten-Shorrer, M. & Sonis, S. T. The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies. CA Cancer J. Clin. 72, 57\u201377. https:\/\/doi.org\/10.3322\/caac.21704 (2022).","journal-title":"CA Cancer J. Clin."},{"key":"28486_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.suponc.2011.04.009","volume":"9","author":"JM Bowen","year":"2011","unstructured":"Bowen, J. M., Gibson, R. J. & Keefe, D. M. Animal models of mucositis: Implications for therapy. J. Support. Oncol. 9, 161\u2013168 (2011).","journal-title":"J. Support. Oncol."},{"key":"28486_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/SPC.0000000000000421","volume":"13","author":"HR Wardill","year":"2019","unstructured":"Wardill, H. R., Tissing, W. J., Kissow, H. & Stringer, A. M. Animal models of mucositis: Critical tools for advancing pathobiological understanding and identifying therapeutic targets. Curr. Opin. Support. Palliat. Care 13, 119\u2013133 (2019).","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"28486_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00280-010-1451-5","volume":"68","author":"ZQ Wu","year":"2011","unstructured":"Wu, Z. Q. et al. Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice. Cancer Chemother. Pharmacol. 68, 87\u201396. https:\/\/doi.org\/10.1007\/s00280-010-1451-5 (2011).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"28486_CR26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.curtheres.2011.11.003","volume":"72","author":"D Tung","year":"2011","unstructured":"Tung, D., Cheung, P. H., Tudor, G., Booth, C. & Saha, S. In vivo effects of immunomodulators in a murine model of fluorouracil-induced mucositis. Curr. Ther. Res. 72, 262\u2013272. https:\/\/doi.org\/10.1016\/j.curtheres.2011.11.003 (2011).","journal-title":"Curr. Ther. Res."},{"key":"28486_CR27","doi-asserted-by":"publisher","first-page":"e0116213","DOI":"10.1371\/journal.pone.0116213","volume":"10","author":"S Kato","year":"2015","unstructured":"Kato, S. et al. Saireito (TJ-114), a Japanese traditional herbal medicine, reduces 5-fluorouracil-induced intestinal mucositis in mice by inhibiting cytokine-mediated apoptosis in intestinal crypt cells. PLOS ONE 10, e0116213. https:\/\/doi.org\/10.1371\/journal.pone.0116213 (2015).","journal-title":"PLOS ONE"},{"key":"28486_CR28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ijrobp.2006.05.025","volume":"66","author":"L Borges","year":"2006","unstructured":"Borges, L. et al. A protective role for keratinocyte growth factor in a murine model of chemotherapy and radiotherapy-induced mucositis. Int. J. Radiat. Oncol. Biol. Phys. 66, 254\u2013262. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.05.025 (2006).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"28486_CR29","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/jop.12473","volume":"46","author":"MP Patricia","year":"2017","unstructured":"Patricia, M. P., Francisco, G. G., Francisco, M. D., Rui, A. M. & Pia, L.-J. The therapeutic effects of apigenin and dexamethasone on 5-fluorouracil-induced oral mucositis\u2014A pilot study using a Syrian hamster model. J. Oral Pathol. Med. 46, 142\u2013147. https:\/\/doi.org\/10.1111\/jop.12473 (2017).","journal-title":"J. Oral Pathol. Med."},{"key":"28486_CR30","doi-asserted-by":"publisher","first-page":"e304","DOI":"10.4317\/jced.52198","volume":"7","author":"O Koohi-Hosseinabadi","year":"2015","unstructured":"Koohi-Hosseinabadi, O. et al. Comparison of the therapeutic effects of the dietary and topical forms of Zizyphus jujuba extract on oral mucositis induced by 5-fluorouracil: A golden hamster model. J. Clin. Exp. Dent. 7, e304\u2013e309. https:\/\/doi.org\/10.4317\/jced.52198 (2015).","journal-title":"J. Clin. Exp. Dent."},{"key":"28486_CR31","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.colsurfb.2018.04.047","volume":"167","author":"I Takeuchi","year":"2018","unstructured":"Takeuchi, I., Kamiki, Y. & Makino, K. Therapeutic efficacy of rebamipide-loaded PLGA nanoparticles coated with chitosan in a mouse model for oral mucositis induced by cancer chemotherapy. Colloids Surf. B 167, 468\u2013473. https:\/\/doi.org\/10.1016\/j.colsurfb.2018.04.047 (2018).","journal-title":"Colloids Surf. B"},{"key":"28486_CR32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.21873\/anticanres.12223","volume":"38","author":"Y Shimamura","year":"2018","unstructured":"Shimamura, Y., Takeuchi, I., Terada, H. & Makino, K. A mouse model for oral mucositis induced by cancer chemotherapy. Anticancer Res. 38, 307\u2013312. https:\/\/doi.org\/10.21873\/anticanres.12223 (2018).","journal-title":"Anticancer Res."},{"key":"28486_CR33","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.3390\/ijms19102981","volume":"19","author":"S Tancharoen","year":"2018","unstructured":"Tancharoen, S., Shakya, P., Narkpinit, S., Dararat, P. & Kikuchi, K. Anthocyanins extracted from Oryza sativa L. prevent fluorouracil-induced nuclear factor-\u03baB activation in oral mucositis: In vitro and in vivo studies. Int. J. Mol. Sci. 19, 2981 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"28486_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/jcp.20822","volume":"210","author":"BAE de Koning","year":"2007","unstructured":"de Koning, B. A. E. et al. Methotrexate-induced mucositis in mucin 2-deficient mice. J. Cell Physiol. 210, 144\u2013152. https:\/\/doi.org\/10.1002\/jcp.20822 (2007).","journal-title":"J. Cell Physiol."},{"key":"28486_CR35","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.biopha.2018.07.029","volume":"106","author":"S Zhang","year":"2018","unstructured":"Zhang, S. et al. Assessment of dose-response relationship of 5-fluorouracil to murine intestinal injury. Biomed. Pharmacother. 106, 910\u2013916. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.029 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"28486_CR36","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.pedneo.2018.07.007","volume":"60","author":"L Huang","year":"2019","unstructured":"Huang, L. et al. SCID\/NOD mice model for 5-FU induced intestinal mucositis: Safety and effects of probiotics as therapy. Pediatr. Neonatol. 60, 252\u2013260. https:\/\/doi.org\/10.1016\/j.pedneo.2018.07.007 (2019).","journal-title":"Pediatr. Neonatol."},{"key":"28486_CR37","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/cancers11060857","volume":"11","author":"D Basile","year":"2019","unstructured":"Basile, D. et al. Mucosal injury during anti-cancer treatment: from pathobiology to bedside. Cancers 11, 857 (2019).","journal-title":"Cancers"},{"key":"28486_CR38","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.oraloncology.2009.08.006","volume":"45","author":"ST Sonis","year":"2009","unstructured":"Sonis, S. T. Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol. 45, 1015\u20131020. https:\/\/doi.org\/10.1016\/j.oraloncology.2009.08.006 (2009).","journal-title":"Oral Oncol."},{"key":"28486_CR39","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3389\/fphar.2017.00354","volume":"8","author":"M Cinausero","year":"2017","unstructured":"Cinausero, M. et al. New frontiers in the pathobiology and treatment of cancer regimen-related mucosal injury. Front. Pharmacol. 8, 354. https:\/\/doi.org\/10.3389\/fphar.2017.00354 (2017).","journal-title":"Front. Pharmacol."},{"key":"28486_CR40","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1136\/gut.47.5.632","volume":"47","author":"DM Keefe","year":"2000","unstructured":"Keefe, D. M., Brealey, J., Goland, G. J. & Cummins, A. G. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 47, 632\u2013637. https:\/\/doi.org\/10.1136\/gut.47.5.632 (2000).","journal-title":"Gut"},{"key":"28486_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00520-003-0550-9","volume":"12","author":"DMK Keefe","year":"2004","unstructured":"Keefe, D. M. K. Gastrointestinal mucositis: A new biological model. Support. Care Cancer 12, 6\u20139. https:\/\/doi.org\/10.1007\/s00520-003-0550-9 (2004).","journal-title":"Support. Care Cancer"},{"key":"28486_CR42","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3390\/nu5051488","volume":"5","author":"AM Stringer","year":"2013","unstructured":"Stringer, A. M. Interaction between host cells and microbes in chemotherapy-induced mucositis. Nutrients 5, 1488\u20131499. https:\/\/doi.org\/10.3390\/nu5051488 (2013).","journal-title":"Nutrients"},{"key":"28486_CR43","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.tranon.2017.05.001","volume":"10","author":"M Bertolini","year":"2017","unstructured":"Bertolini, M., Sobue, T., Thompson, A. & Dongari-Bagtzoglou, A. Chemotherapy induces oral mucositis in mice without additional noxious stimuli. Transl. Oncol. 10, 612\u2013620 (2017).","journal-title":"Transl. Oncol."},{"key":"28486_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/ijos.2013.46","volume":"5","author":"KB Jones","year":"2013","unstructured":"Jones, K. B. & Klein, O. D. Oral epithelial stem cells in tissue maintenance and disease: The first steps in a long journey. Int. J. Oral Sci. 5, 121\u2013129. https:\/\/doi.org\/10.1038\/ijos.2013.46 (2013).","journal-title":"Int. J. Oral Sci."},{"key":"28486_CR45","volume-title":"Comparative Anatomy and Histology: A Mouse, Rat, and Human Atlas","author":"PM Treuting","year":"2017","unstructured":"Treuting, P. M., Dintzis, S. M. & Montine, K. S. Comparative Anatomy and Histology: A Mouse, Rat, and Human Atlas (Academic Press, Cambridge, 2017)."},{"key":"28486_CR46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2209\/tdcpublication.49.199","volume":"49","author":"VC Carrard","year":"2008","unstructured":"Carrard, V. C. et al. Effects of aging on mouse tongue epithelium focusing on cell proliferation rate and morphological aspects. Bull. Tokyo Dent. Coll. 49, 199\u2013205 (2008).","journal-title":"Bull. Tokyo Dent. Coll."},{"key":"28486_CR47","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1186\/s12885-018-4862-z","volume":"18","author":"S Dote","year":"2018","unstructured":"Dote, S. et al. Oral mucositis associated with anti-EGFR therapy in colorectal cancer: Single institutional retrospective cohort study. BMC Cancer 18, 957. https:\/\/doi.org\/10.1186\/s12885-018-4862-z (2018).","journal-title":"BMC Cancer"},{"key":"28486_CR48","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/1097-0142(19830415)51:8<1353::AID-CNCR2820510805>3.0.CO;2-I","volume":"51","author":"DA Decker","year":"1983","unstructured":"Decker, D. A. et al. Adjuvant chemotherapy with cis-diamminodichloroplatinum II and 120\u00a0h infusion 5-fluorouracil in Stage III and IV squamous cell carcinoma of the head and neck. Cancer 51, 1353\u20131355 (1983).","journal-title":"Cancer"},{"key":"28486_CR49","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1182\/blood-2016-12-754994","volume":"129","author":"CEM de Mooij","year":"2017","unstructured":"de Mooij, C. E. M., Netea, M. G., van der Velden, W. J. F. M. & Blijlevens, N. M. A. Targeting the interleukin-1 pathway in patients with hematological disorders. Blood 129, 3155\u20133164. https:\/\/doi.org\/10.1182\/blood-2016-12-754994 (2017).","journal-title":"Blood"},{"key":"28486_CR50","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1007\/s00520-011-1343-1","volume":"20","author":"KKF Cheng","year":"2012","unstructured":"Cheng, K. K. F., Lee, V., Li, C. H., Yuen, H. L. & Epstein, J. B. Oral mucositis in pediatric and adolescent patients undergoing chemotherapy: The impact of symptoms on quality of life. Support. Care Cancer 20, 2335\u20132342 (2012).","journal-title":"Support. Care Cancer"},{"key":"28486_CR51","first-page":"1531","volume":"98","author":"LS Elting","year":"2003","unstructured":"Elting, L. S. et al. The burdens of cancer therapy: Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer Interdiscip. Int. J. Am. Cancer Soc. 98, 1531\u20131539 (2003).","journal-title":"Cancer Interdiscip. Int. J. Am. Cancer Soc."},{"key":"28486_CR52","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1200\/JCO.2001.19.8.2201","volume":"19","author":"ST Sonis","year":"2001","unstructured":"Sonis, S. T. et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 19, 2201\u20132205 (2001).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"28486_CR53","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1097\/j.pain.0000000000000498","volume":"157","author":"K Yamaguchi","year":"2016","unstructured":"Yamaguchi, K. et al. Distinct TRPV1- and TRPA1-based mechanisms underlying enhancement of oral ulcerative mucositis-induced pain by 5-fluorouracil. Pain 157, 1004\u20131020. https:\/\/doi.org\/10.1097\/j.pain.0000000000000498 (2016).","journal-title":"Pain"},{"key":"28486_CR54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ctrv.2016.08.002","volume":"50","author":"D Meulendijks","year":"2016","unstructured":"Meulendijks, D., Cats, A., Beijnen, J. H. & Schellens, J. H. M. Improving safety of fluoropyrimidine chemotherapy by individualizing treatment based on dihydropyrimidine dehydrogenase activity\u2014Ready for clinical practice?. Cancer Treat. Rev. 50, 23\u201334. https:\/\/doi.org\/10.1016\/j.ctrv.2016.08.002 (2016).","journal-title":"Cancer Treat. Rev."},{"key":"28486_CR55","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1023\/A:1006416410198","volume":"18","author":"JL Grem","year":"2000","unstructured":"Grem, J. L. 5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development. Investig. New Drugs 18, 299\u2013313 (2000).","journal-title":"Investig. New Drugs"},{"key":"28486_CR56","first-page":"e4007","volume":"16","author":"M Curra","year":"2018","unstructured":"Curra, M., Soares Junior, L. A. V., Martins, M. D. & Santos, P. S. D. S. Chemotherapy protocols and incidence of oral mucositis. An integrative review. Einstein Sao Paulo 16, e4007\u2013e4007 (2018).","journal-title":"Einstein Sao Paulo"},{"key":"28486_CR57","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1476-4598-10-12","volume":"10","author":"R Wilken","year":"2011","unstructured":"Wilken, R., Veena, M. S., Wang, M. B. & Srivatsan, E. S. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol. Cancer 10, 12 (2011).","journal-title":"Mol. Cancer"},{"key":"28486_CR58","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1007\/s10620-013-2826-3","volume":"58","author":"C Chen","year":"2013","unstructured":"Chen, C. et al. Protective effect of amifostine on high-dose methotrexate-induced small intestinal mucositis in mice. Dig. Dis. Sci. 58, 3134\u20133143 (2013).","journal-title":"Dig. Dis. Sci."},{"key":"28486_CR59","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/bcpt.12841","volume":"121","author":"Z Liu","year":"2017","unstructured":"Liu, Z. et al. Oral administration of polaprezinc attenuates fluorouracil-induced intestinal mucositis in a mouse model. Basic Clin. Pharmacol. Toxicol. 121, 480\u2013486 (2017).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"28486_CR60","doi-asserted-by":"publisher","first-page":"153473541983379","DOI":"10.1177\/1534735419833795","volume":"18","author":"C-H Li","year":"2019","unstructured":"Li, C.-H. et al. The protective role of GMI, an immunomodulatory protein from Ganoderma microsporum, on 5-fluorouracil-induced oral and intestinal Mucositis. Integr. Cancer Ther. 18, 1534735419833795 (2019).","journal-title":"Integr. Cancer Ther."},{"key":"28486_CR61","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/0030-4220(90)90376-4","volume":"69","author":"ST Sonis","year":"1990","unstructured":"Sonis, S. T., Tracey, C., Shklar, G., Jenson, J. & Florine, D. An animal model for mucositis induced by cancer chemotherapy. Oral Surg. Oral Med. Oral Pathol. 69, 437\u2013443 (1990).","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"28486_CR62","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s10147-015-0791-x","volume":"20","author":"T Kajiwara","year":"2015","unstructured":"Kajiwara, T. et al. Gastrointestinal toxicities of 5-fluorouracil increase the proportion of regulatory T cells in intestinal tract: Advantages of alternate-day S-1 administration. Int. J. Clin. Oncol. 20, 913\u2013921. https:\/\/doi.org\/10.1007\/s10147-015-0791-x (2015).","journal-title":"Int. J. Clin. Oncol."},{"key":"28486_CR63","doi-asserted-by":"publisher","first-page":"e0135102","DOI":"10.1371\/journal.pone.0135102","volume":"10","author":"C-T Chang","year":"2015","unstructured":"Chang, C.-T. et al. Comprehensive assessment of host responses to 5-fluorouracil-induced oral mucositis through transcriptomic analysis. PLOS ONE 10, e0135102. https:\/\/doi.org\/10.1371\/journal.pone.0135102 (2015).","journal-title":"PLOS ONE"},{"key":"28486_CR64","first-page":"3","volume":"5","author":"ST Sonis","year":"2007","unstructured":"Sonis, S. T. Pathobiology of oral mucositis: Novel insights and opportunities. J. Support. Oncol. 5, 3\u201311 (2007).","journal-title":"J. Support. Oncol."},{"key":"28486_CR65","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1177\/1535370215581309","volume":"240","author":"B Vanhoecke","year":"2015","unstructured":"Vanhoecke, B. et al. Dark Agouti rat model of chemotherapy-induced mucositis: Establishment and current state of the art. Exp. Biol. Med. 240, 725\u2013741. https:\/\/doi.org\/10.1177\/1535370215581309 (2015).","journal-title":"Exp. Biol. Med."},{"key":"28486_CR66","doi-asserted-by":"publisher","first-page":"G231","DOI":"10.1152\/ajpgi.00204.2017","volume":"314","author":"PT Sangild","year":"2018","unstructured":"Sangild, P. T., Shen, R. L., Pontoppidan, P. & Rathe, M. Animal models of chemotherapy-induced mucositis: translational relevance and challenges. Am. J. Physiol. Gastrointest. Liver Physiol. 314, G231\u2013G246 (2018).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"28486_CR67","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1093\/jnci\/87.24.1876","volume":"87","author":"N Ikuno","year":"1995","unstructured":"Ikuno, N., Soda, H., Watanabe, M. & Oka, M. Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum. JNCI J. Natl. Cancer Inst. 87, 1876\u20131883. https:\/\/doi.org\/10.1093\/jnci\/87.24.1876 (1995).","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"28486_CR68","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1046\/j.1440-1746.2003.03136.x","volume":"18","author":"RJ Gibson","year":"2003","unstructured":"Gibson, R. J., Bowen, J. M., Inglis, M. R., Cummins, A. G. & Keefe, D. M. Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. J. Gastroenterol. Hepatol. 18, 1095\u20131100. https:\/\/doi.org\/10.1046\/j.1440-1746.2003.03136.x (2003).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"28486_CR69","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/01635581.2015.989369","volume":"67","author":"T Zuo","year":"2015","unstructured":"Zuo, T. et al. The squid ink polysaccharides protect tight junctions and adherens junctions from chemotherapeutic injury in the small intestinal epithelium of mice. Nutr. Cancer 67, 364\u2013371 (2015).","journal-title":"Nutr. Cancer"},{"key":"28486_CR70","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00280-008-0732-8","volume":"63","author":"RM Logan","year":"2009","unstructured":"Logan, R. M. et al. Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered?. Cancer Chemother. Pharmacol. 63, 239\u2013251. https:\/\/doi.org\/10.1007\/s00280-008-0732-8 (2009).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"28486_CR71","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.nut.2011.09.007","volume":"28","author":"VL Bodiga","year":"2012","unstructured":"Bodiga, V. L. et al. Effect of vitamin supplementation on cisplatin-induced intestinal epithelial cell apoptosis in Wistar\/NIN rats. Nutrition 28, 572\u2013580. https:\/\/doi.org\/10.1016\/j.nut.2011.09.007 (2012).","journal-title":"Nutrition"},{"key":"28486_CR72","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/BF00686151","volume":"31","author":"S Castellino","year":"1993","unstructured":"Castellino, S. et al. Development of a model of melphalan-induced gastrointestinal toxicity in mice. Cancer Chemother. Pharmacol. 31, 376\u2013380. https:\/\/doi.org\/10.1007\/BF00686151 (1993).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"28486_CR73","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/path.3009","volume":"226","author":"A Kaczmarek","year":"2012","unstructured":"Kaczmarek, A., Brinkman, B. M., Heyndrickx, L., Vandenabeele, P. & Krysko, D. V. Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways. J. Pathol. 226, 598\u2013608. https:\/\/doi.org\/10.1002\/path.3009 (2012).","journal-title":"J. Pathol."},{"key":"28486_CR74","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/bjc.1992.113","volume":"65","author":"TV Anilkumar","year":"1992","unstructured":"Anilkumar, T. V., Sarraf, C. E., Hunt, T. & Alison, M. R. The nature of cytotoxic drug-induced cell death in murine intestinal crypts. Br. J. Cancer 65, 552\u2013558. https:\/\/doi.org\/10.1038\/bjc.1992.113 (1992).","journal-title":"Br. J. Cancer"},{"key":"28486_CR75","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00280-015-2938-x","volume":"77","author":"VBM Pereira","year":"2016","unstructured":"Pereira, V. B. M. et al. A new animal model of intestinal mucositis induced by the combination of irinotecan and 5-fluorouracil in mice. Cancer Chemother. Pharmacol. 77, 323\u2013332. https:\/\/doi.org\/10.1007\/s00280-015-2938-x (2016).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"28486_CR76","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00280-007-0570-0","volume":"62","author":"RM Logan","year":"2008","unstructured":"Logan, R. M. et al. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: Implications for the pathobiology of mucositis. Cancer Chemother. Pharmacol. 62, 33\u201341. https:\/\/doi.org\/10.1007\/s00280-007-0570-0 (2008).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"28486_CR77","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1053\/j.soncn.2003.10.004","volume":"20","author":"CG Brown","year":"2004","unstructured":"Brown, C. G. & Wingard, J. Clinical consequences of oral mucositis1 1The opinions or assertions contained herein are the private views of the author and are not to be construed as official or as reflecting the views of the department of the army or the department of defense. Semin. Oncol. Nurs. 20, 16\u201321. https:\/\/doi.org\/10.1053\/j.soncn.2003.10.004 (2004).","journal-title":"Semin. Oncol. Nurs."},{"key":"28486_CR78","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.3390\/ijerph17072464","volume":"17","author":"A Kusiak","year":"2020","unstructured":"Kusiak, A., Jereczek-Fossa, B. A., Cicho\u0144ska, D. & Alterio, D. Oncological-therapy related oral mucositis as an interdisciplinary problem\u2014Literature review. Int. J. Environ. Res. Public Health 17, 2464. https:\/\/doi.org\/10.3390\/ijerph17072464 (2020).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"28486_CR79","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-907673-46-7","volume-title":"Oral Mucositis","author":"S Sonis","year":"2012","unstructured":"Sonis, S. Oral Mucositis (Springer Science & Business Media, Tarporley, 2012)."},{"key":"28486_CR80","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/s1368-8375(99)00075-5","volume":"36","author":"D Etiz","year":"2000","unstructured":"Etiz, D. et al. Clinical and histopathological evaluation of sucralfate in prevention of oral mucositis induced by radiation therapy in patients with head and neck malignancies. Oral Oncol. 36, 116\u2013120. https:\/\/doi.org\/10.1016\/s1368-8375(99)00075-5 (2000).","journal-title":"Oral Oncol."},{"key":"28486_CR81","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1038\/bjc.1998.279","volume":"77","author":"R Symonds","year":"1998","unstructured":"Symonds, R. Treatment-induced mucositis: An old problem with new remedies. Br. J. Cancer 77, 1689\u20131695 (1998).","journal-title":"Br. J. Cancer"},{"key":"28486_CR82","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1200\/JCO.1998.16.9.3169","volume":"16","author":"S Wadler","year":"1998","unstructured":"Wadler, S. et al. Recommended guidelines for the treatment of chemotherapy-induced diarrhea. J. Clin. Oncol. 16, 3169\u20133178 (1998).","journal-title":"J. Clin. Oncol."},{"key":"28486_CR83","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1200\/JCO.2004.04.132","volume":"22","author":"AB Benson III","year":"2004","unstructured":"Benson, A. B. III. et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J. Clin. Oncol. 22, 2918\u20132926 (2004).","journal-title":"J. Clin. Oncol."},{"key":"28486_CR84","doi-asserted-by":"publisher","first-page":"G1133","DOI":"10.1152\/ajpgi.00535.2011","volume":"302","author":"M Yasuda","year":"2012","unstructured":"Yasuda, M. et al. Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G1133-1142. https:\/\/doi.org\/10.1152\/ajpgi.00535.2011 (2012).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"28486_CR85","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cyto.2012.10.003","volume":"61","author":"PMG Soares","year":"2013","unstructured":"Soares, P. M. G. et al. Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4. Cytokine 61, 46\u201349. https:\/\/doi.org\/10.1016\/j.cyto.2012.10.003 (2013).","journal-title":"Cytokine"},{"key":"28486_CR86","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.toxrep.2015.06.006","volume":"2","author":"AK Al-Asmari","year":"2015","unstructured":"Al-Asmari, A. K., Khan, A. Q., Al-Qasim, A. M. & Al-Yousef, Y. Ascorbic acid attenuates antineoplastic drug 5-fluorouracil induced gastrointestinal toxicity in rats by modulating the expression of inflammatory mediators. Toxicol. Rep. 2, 908\u2013916. https:\/\/doi.org\/10.1016\/j.toxrep.2015.06.006 (2015).","journal-title":"Toxicol. Rep."},{"key":"28486_CR87","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3322\/canjclin.52.2.72","volume":"52","author":"A Inui","year":"2002","unstructured":"Inui, A. Cancer anorexia-cachexia syndrome: Current issues in research and management. CA Cancer J. Clin. 52, 72\u201391. https:\/\/doi.org\/10.3322\/canjclin.52.2.72 (2002).","journal-title":"CA Cancer J. Clin."},{"key":"28486_CR88","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3892\/ol.2014.1856","volume":"7","author":"Z Cao","year":"2014","unstructured":"Cao, Z. et al. Antitumor and immunomodulatory effects of low-dose 5-FU on hepatoma 22 tumor-bearing mice. Oncol. Lett. 7, 1260\u20131264. https:\/\/doi.org\/10.3892\/ol.2014.1856 (2014).","journal-title":"Oncol. Lett."},{"key":"28486_CR89","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cei.12922","volume":"188","author":"U Jain","year":"2017","unstructured":"Jain, U. et al. Properdin deficiency protects from 5-fluorouracil-induced small intestinal mucositis in a complement activation-independent, interleukin-10-dependent mechanism. Clin. Exp. Immunol. 188, 36\u201344. https:\/\/doi.org\/10.1111\/cei.12922 (2017).","journal-title":"Clin. Exp. Immunol."},{"key":"28486_CR90","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00280-002-0460-4","volume":"50","author":"RJ Gibson","year":"2002","unstructured":"Gibson, R. J. et al. The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer. Cancer Chemother. Pharmacol. 50, 53\u201358. https:\/\/doi.org\/10.1007\/s00280-002-0460-4 (2002).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"28486_CR91","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/01635580802192841","volume":"60","author":"CL Smith","year":"2008","unstructured":"Smith, C. L. et al. Lactobacillus fermentum BR11 and fructo-oligosaccharide partially reduce jejunal inflammation in a model of intestinal mucositis in rats. Nutr. Cancer 60, 757\u2013767. https:\/\/doi.org\/10.1080\/01635580802192841 (2008).","journal-title":"Nutr. Cancer"},{"key":"28486_CR92","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.4161\/cbt.6.9.4622","volume":"6","author":"JM Bowen","year":"2007","unstructured":"Bowen, J. M. et al. VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss. Cancer Biol. Ther. 6, 1449\u20131454 (2007).","journal-title":"Cancer Biol. Ther."},{"key":"28486_CR93","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1758834009355164","volume":"2","author":"A Stein","year":"2010","unstructured":"Stein, A., Voigt, W. & Jordan, K. Chemotherapy-induced diarrhea: Pathophysiology, frequency and guideline-based management. Ther. Adv. Med. Oncol. 2, 51\u201363 (2010).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"28486_CR94","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.tox.2005.09.017","volume":"217","author":"K Moriyama","year":"2006","unstructured":"Moriyama, K. et al. Diamine oxidase, a plasma biomarker in rats to GI tract toxicity of oral fluorouracil anti-cancer drugs. Toxicology 217, 233\u2013239. https:\/\/doi.org\/10.1016\/j.tox.2005.09.017 (2006).","journal-title":"Toxicology"},{"key":"28486_CR95","doi-asserted-by":"publisher","first-page":"168","DOI":"10.2174\/138920021603150812120640","volume":"16","author":"T Lazarevi\u0107-Pasti","year":"2015","unstructured":"Lazarevi\u0107-Pasti, T., Leskovac, A. & Vasi\u0107, V. Myeloperoxidase inhibitors as potential drugs. Curr. Drug Metab. 16, 168\u2013190. https:\/\/doi.org\/10.2174\/138920021603150812120640 (2015).","journal-title":"Curr. Drug Metab."},{"key":"28486_CR96","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/0016-5085(95)90065-9","volume":"108","author":"L Santucci","year":"1995","unstructured":"Santucci, L., Fiorucci, S., Di Matteo, F. M. & Morelli, A. Role of tumor necrosis factor alpha release and leukocyte margination in indomethacin-induced gastric injury in rats. Gastroenterology 108, 393\u2013401. https:\/\/doi.org\/10.1016\/0016-5085(95)90065-9 (1995).","journal-title":"Gastroenterology"},{"key":"28486_CR97","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/0016-5085(84)90202-6","volume":"87","author":"JE Krawisz","year":"1984","unstructured":"Krawisz, J. E., Sharon, P. & Stenson, W. F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87, 1344\u20131350 (1984).","journal-title":"Gastroenterology"},{"key":"28486_CR98","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1021\/bi602587k","volume":"46","author":"AJ Kettle","year":"2007","unstructured":"Kettle, A. J., Anderson, R. F., Hampton, M. B. & Winterbourn, C. C. Reactions of superoxide with myeloperoxidase. Biochemistry 46, 4888\u20134897 (2007).","journal-title":"Biochemistry"},{"key":"28486_CR99","doi-asserted-by":"publisher","first-page":"20515","DOI":"10.1073\/pnas.0911412106","volume":"106","author":"Y Xu","year":"2009","unstructured":"Xu, Y., Sz\u00e9p, S. & Lu, Z. The antioxidant role of thiocyanate in the pathogenesis of cystic fibrosis and other inflammation-related diseases. Proc. Natl. Acad. Sci. U. S. A. 106, 20515\u201320519. https:\/\/doi.org\/10.1073\/pnas.0911412106 (2009).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"28486_CR100","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0167-8140(83)80018-8","volume":"1","author":"CS Parkins","year":"1983","unstructured":"Parkins, C. S., Fowler, J. F. & Yu, S. A murine model of lip epidermal\/mucosal reactions to X-irradiation. Radiother. Oncol. 1, 159\u2013165. https:\/\/doi.org\/10.1016\/S0167-8140(83)80018-8 (1983).","journal-title":"Radiother. Oncol."},{"issue":"6","key":"28486_CR101","doi-asserted-by":"publisher","first-page":"e711","DOI":"10.4317\/medoral.17057","volume":"16","author":"C-Y Li","year":"2011","unstructured":"Li, C.-Y., Hong, Y., Tao, X.-A., Xia, J. & Cheng, B. The correlation between the severity of radiotherapy-induced glossitis and endothelial cell injury in local tissues in a rat model. Med. Oral Patol. Oral Cir. Bucal 16(6), e711\u2013e715 (2011).","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"28486_CR102","doi-asserted-by":"publisher","first-page":"e85184","DOI":"10.1371\/journal.pone.0085184","volume":"9","author":"KY Cheah","year":"2014","unstructured":"Cheah, K. Y., Howarth, G. S. & Bastian, S. E. Grape seed extract dose-responsively decreases disease severity in a rat model of mucositis; concomitantly enhancing chemotherapeutic effectiveness in colon cancer cells. PLoS One 9, e85184. https:\/\/doi.org\/10.1371\/journal.pone.0085184 (2014).","journal-title":"PLoS One"},{"key":"28486_CR103","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.oooo.2015.04.012","volume":"120","author":"H Miyamoto","year":"2015","unstructured":"Miyamoto, H. et al. The relationship between the severity of radiation-induced oral mucositis and the myeloperoxidase levels in rats. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 120, 329\u2013336. https:\/\/doi.org\/10.1016\/j.oooo.2015.04.012 (2015).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"28486_CR104","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s10620-006-9464-y","volume":"52","author":"CA Mauger","year":"2007","unstructured":"Mauger, C. A., Butler, R. N., Geier, M. S., Tooley, K. L. & Howarth, G. S. Probiotic effects on 5-fluorouracil-induced mucositis assessed by the sucrose breath test in rats. Dig. Dis. Sci. 52, 612\u2013619. https:\/\/doi.org\/10.1007\/s10620-006-9464-y (2007).","journal-title":"Dig. Dis. Sci."},{"key":"28486_CR105","doi-asserted-by":"publisher","first-page":"593","DOI":"10.4161\/cbt.5.6.2659","volume":"5","author":"KL Tooley","year":"2006","unstructured":"Tooley, K. L., Howarth, G. S., Lymn, K. A., Lawrence, A. & Butler, R. N. Oral ingestion of streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate treated rats. Cancer Biol. Ther. 5, 593\u2013600. https:\/\/doi.org\/10.4161\/cbt.5.6.2659 (2006).","journal-title":"Cancer Biol. Ther."},{"key":"28486_CR106","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1046\/j.1365-2036.2003.01784.x","volume":"18","author":"M Duncan","year":"2003","unstructured":"Duncan, M. & Grant, G. Oral and intestinal mucositis\u2014Causes and possible treatments. Aliment. Pharmacol. Ther. 18, 853\u2013874. https:\/\/doi.org\/10.1046\/j.1365-2036.2003.01784.x (2003).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"28486_CR107","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.3390\/nu5103948","volume":"5","author":"E Bateman","year":"2013","unstructured":"Bateman, E. et al. Investigation of effect of nutritional drink on chemotherapy-induced mucosal injury and tumor growth in an established animal model. Nutrients 5, 3948\u20133963 (2013).","journal-title":"Nutrients"},{"key":"28486_CR108","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3945\/an.110.000141","volume":"2","author":"J Bauer","year":"2011","unstructured":"Bauer, J., J\u00fcrgens, H. & Fr\u00fchwald, M. C. Important aspects of nutrition in children with cancer. Adv. Nutr. 2, 67\u201377. https:\/\/doi.org\/10.3945\/an.110.000141 (2011).","journal-title":"Adv. Nutr."},{"key":"28486_CR109","doi-asserted-by":"publisher","first-page":"72S","DOI":"10.1177\/014860719201600607","volume":"16","author":"MH Torosian","year":"1992","unstructured":"Torosian, M. H. Stimulation of tumor growth by nutrition support. J. Parenter. Enter. Nutr. 16, 72S-75S. https:\/\/doi.org\/10.1177\/014860719201600607 (1992).","journal-title":"J. Parenter. Enter. Nutr."},{"key":"28486_CR110","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000107724","volume":"53","author":"M Manzano","year":"2007","unstructured":"Manzano, M. et al. Intestinal toxicity induced by 5-fluorouracil in pigs: A new preclinical model. Chemotherapy 53, 344\u2013355 (2007).","journal-title":"Chemotherapy"},{"key":"28486_CR111","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.4161\/cbt.5.9.3117","volume":"5","author":"GS Howarth","year":"2006","unstructured":"Howarth, G. S., Tooley, K. L., Davidson, G. P. & Butler, R. N. A non-invasive method for detection of intestinal mucositis induced by different classes of chemotherapy drugs in the rat. Cancer Biol. Ther. 5, 1189\u20131195. https:\/\/doi.org\/10.4161\/cbt.5.9.3117 (2006).","journal-title":"Cancer Biol. Ther."},{"key":"28486_CR112","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1186\/s12864-015-2168-y","volume":"16","author":"J Zheng","year":"2015","unstructured":"Zheng, J. et al. Gene expression profiling in non-human primate jejunum, ileum and colon after total-body irradiation: A comparative study of segment-specific molecular and cellular responses. BMC Genomics 16, 984. https:\/\/doi.org\/10.1186\/s12864-015-2168-y (2015).","journal-title":"BMC Genomics"},{"key":"28486_CR113","doi-asserted-by":"publisher","DOI":"10.1017\/S0962728600005674","volume-title":"New Edition of the Australian Code for the Care and Use of Animals for Scientific Purposes","author":"NHMRC","year":"2013","unstructured":"NHMRC. New Edition of the Australian Code for the Care and Use of Animals for Scientific Purposes (Cambridge University Press, Cambridge, 2013). https:\/\/doi.org\/10.1017\/S0962728600005674."},{"key":"28486_CR114","doi-asserted-by":"publisher","unstructured":"Brown, M. F. et al. Loss of Caspase-3 sensitizes colon cancer cells to genotoxic stress via RIP1-dependent necrosis. Cell Death Amp. Disease 6, e1729 https:\/\/doi.org\/10.1038\/cddis.2015.104https:\/\/www.nature.com\/articles\/cddis2015104#supplementary-information (2015).","DOI":"10.1038\/cddis.2015.104"},{"key":"28486_CR115","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw, S., Nihal, M. & Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 22, 659\u2013661 (2008).","journal-title":"FASEB J."},{"key":"28486_CR116","first-page":"3495","volume":"32","author":"K Kanetaka","year":"2012","unstructured":"Kanetaka, K. et al. Effects of intermittent 5-fluorouracil and low-dose cisplatin therapy on advanced and recurrent gastric cancer. Anticancer Res. 32, 3495\u20133499 (2012).","journal-title":"Anticancer Res."},{"key":"28486_CR117","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.ctrv.2014.08.002","volume":"40","author":"E Winquist","year":"2014","unstructured":"Winquist, E., Al-Rasheedy, I., Nichols, A. C., Palma, D. A. & Stitt, L. Temporal changes in the efficacy of chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck: A systematic review and meta-analysis. Cancer Treat. Rev. 40, 1073\u20131079 (2014).","journal-title":"Cancer Treat. Rev."},{"key":"28486_CR118","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jphs.2015.02.001","volume":"127","author":"N Nakajima","year":"2015","unstructured":"Nakajima, N. et al. Evaluation of edaravone against radiation-induced oral mucositis in mice. J. Pharmacol. Sci. 127, 339\u2013343. https:\/\/doi.org\/10.1016\/j.jphs.2015.02.001 (2015).","journal-title":"J. Pharmacol. Sci."},{"key":"28486_CR119","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S1368-8375(00)00012-9","volume":"36","author":"ST Sonis","year":"2000","unstructured":"Sonis, S. T. et al. Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncol. 36, 373\u2013381. https:\/\/doi.org\/10.1016\/S1368-8375(00)00012-9 (2000).","journal-title":"Oral Oncol."},{"key":"28486_CR120","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1158\/1078-0432.CCR-05-0403","volume":"11","author":"TM Muanza","year":"2005","unstructured":"Muanza, T. M. et al. Evaluation of radiation-induced oral mucositis by optical coherence tomography. Clin. Cancer Res. 11, 5121\u20135127. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-0403 (2005).","journal-title":"Clin. Cancer Res."},{"key":"28486_CR121","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"28486_CR122","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: An open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"issue":"133","key":"28486_CR123","first-page":"e54161","volume":"13","author":"AB Bialkowska","year":"2016","unstructured":"Bialkowska, A. B., Ghaleb, A. M., Nandan, M. O. & Yang, V. W. Improved Swiss-rolling technique for intestinal tissue preparation for immunohistochemical and immunofluorescent analyses. JoVE J. Vis. Experiments 13(133), e54161 (2016).","journal-title":"JoVE J. Vis. Experiments"},{"key":"28486_CR124","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/cpmo.2","volume":"6","author":"JM Williams","year":"2016","unstructured":"Williams, J. M., Duckworth, C. A., Vowell, K., Burkitt, M. D. & Pritchard, D. M. Intestinal preparation techniques for histological analysis in the mouse. Current Protocols Mouse Biol. 6, 148\u2013168 (2016).","journal-title":"Current Protocols Mouse Biol."},{"key":"28486_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 1\u20137 (2017).","journal-title":"Sci. Rep."},{"key":"28486_CR126","first-page":"14649","volume":"8","author":"J Navarrete","year":"2015","unstructured":"Navarrete, J., V\u00e1squez, B. & del Sol, M. Morphoquantitative analysis of the Ileum of C57BL\/6 mice (Mus musculus) fed with a high-fat diet. Int. J. Clin. Exp. Pathol. 8, 14649 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"28486_CR127","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.immuni.2018.03.003","volume":"48","author":"LA O'Reilly","year":"2018","unstructured":"O\u2019Reilly, L. A. et al. Loss of NF-\u03baB1 causes gastric cancer with aberrant inflammation and expression of immune checkpoint regulators in a STAT-1-dependent manner. Immunity 48, 570-583.e578. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.003 (2018).","journal-title":"Immunity"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28486-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28486-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28486-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T11:12:56Z","timestamp":1674645176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28486-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":127,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["28486"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-28486-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"assertion":[{"value":"22 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1396"}}